Insulet Corporation revised earnings guidance for the year ending December 31, 2024. For the year ending December 31, 2024, the company is raising its expected revenue growth to a range of 14% to 18% (previously 12% to 17%).
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
196.4 USD | -0.41% |
|
-5.03% | -9.48% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.48% | 13.81B | |
-6.81% | 180B | |
-5.94% | 99.21B | |
-6.12% | 66.25B | |
-10.92% | 44.74B | |
+7.88% | 43.82B | |
+10.35% | 41.96B | |
+11.37% | 28.98B | |
+16.18% | 24.07B | |
-9.33% | 23.5B |
- Stock Market
- Equities
- PODD Stock
- News Insulet Corporation
- Insulet Corporation Revises Earnings Guidance for the Year Ending December 31, 2024